DeutschNewstral
Article
Ddailycal.org on 2019-10-05 04:17
UC becomes largest CRISPR-Cas9 patent portfolio holder
Related news
- DUC awarded 12th patent for CRISPR-Cas9 gene-editing technologydailycal.org
- NUC now holds largest CRISPR-Cas9 patent portfolionews.berkeley.edu
- NUC receives its 11th U.S. patent for CRISPR-Cas9news.berkeley.edu
- DTeam including UC Berkeley researcher awarded patent on CRISPR-Cas9 use in all cells amid pending appealdailycal.org
- NUC appeals U.S. patent board decision on CRISPR-Cas9news.berkeley.edu
- DUC files opening brief to appeal CRISPR-Cas9 patent decisiondailycal.org
- DUC receives blow in legal battle over CRISPR-Cas9 patentsdailycal.org
- NEuropean Patent Office to grant UC a broad patent on CRISPR-Cas9news.berkeley.edu
- DUC obtains 8th patent for CRISPR gene-editing methodsdailycal.org
UC granted a key CRISPR patentSan Jose Mercury News- NUC awarded third CRISPR patent, expanding its gene-editing portfolionews.berkeley.edu
- NUC receives patent for use of CRISPR-Cas9 to tune gene expressionnews.berkeley.edu
- DPatent board announces interference between UC, Broad Institute CRISPR patentsdailycal.org
- NPatent awarded for DNA-targeting complex at heart of CRISPR-Cas9 gene editingnews.berkeley.edu
Legal battle gives Broad Institute control of patent for CRISPR/Cas9 gene-editing processThe Japan Times- DUC receives third CRISPR patent after 4 years of litigationdailycal.org
- NUC defends CRISPR patent rights in Court of Appealsnews.berkeley.edu
- NPatent office renews dispute over patent rights to CRISPR-Cas9news.berkeley.edu
- NUniversity of California awarded 15th U.S. CRISPR-Cas9 patentnews.berkeley.edu
- NU.S. patent office indicates it will issue third CRISPR patent to UCnews.berkeley.edu